Wei Jiang - Mar 12, 2024 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Director
Signature
/s/ Nathaniel Sisitsky as attorney-in-fact for Wei Jiang
Stock symbol
STAA
Transactions as of
Mar 12, 2024
Transactions value $
$0
Form type
4
Date filed
3/14/2024, 05:11 PM
Previous filing
Jan 3, 2024
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Award $0 +1.3K $0.00 1.3K Mar 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Restricted Stock Units Award $0 +1.06K $0.00 1.06K Mar 12, 2024 Common Stock 1.06K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective March 12, 2024, the Board of Directors appointed Mr. Jiang to serve as a member of the Board and granted him, as a non-employee director, 1,299 restricted shares, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.
F2 Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.
F3 RSUs granted as compensation for services as a director to non-employee directors who elected to receive shares in lieu of director cash compensation fees. Mr. Jiang has elected to defer delivery of these shares.